Brief: AB Science H1 Operating Loss Widens To 9.6 Million Euros

AB Science SA

30/09/2022 18:02

Sept 30 (Reuters) - AB Science SA  ABS.PA :
    * AB SCIENCE TODAY REPORTS ITS REVENUES FOR THE FIRST HALF
OF 2022
AND PROVIDES AN UPDATE ON ITS ACTIVITIES
    * LAUNCH OF A CONFIRMATORY PHASE 3 STUDY WITH MASITINIB IN
PROGRESSIVE FORMS OF MULTIPLE SCLEROSIS
    * POSITIVE RECOMMENDATION OF DATA AND SAFETY MONITORING
BOARD TO
CONTINUE BOTH PHASE 2 STUDIES IN COVID-19
    * CASH POSITION OF €7.6 MILLION AS OF 30 JUNE 2022
    * OPERATING LOSS OF EUR 9.6 MILLION AS OF 30 JUNE 2022, AN
INCREASE OF 58% COMPARED TO FIRST HALF OF 2021
    * NET LOSS AS OF JUNE 30, 2022 AMOUNTS TO 7,141 KEUR
COMPARED TO A
LOSS OF 4,655 KEUR AS OF JUNE 30, 2021

Source text for Eikon:  urn:newsml:reuters.com:*:nGNXbDV0ph
Further company coverage:  ABS.PA 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))